The drug-induced injury of the upper gastrointestinal tract: prophylaxis and treatment
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
It is well established that non-steroidal anti-inflammatory drugs (NSAIDs) are the causal factor of mucosa damage not only of in the stomach and duodenum, but also in esophagus, triggering the development of gastroesophageal reflux disease (GERD). It is known that NSAIDs’ intake (including low doses of aspirin) can significantly increase the likelihood of developing of the peptic esophagitis with the risk of ulceration, bleeding, or stricture formation. Recent years, there is an increasing number of papers, devoted to the investigation of esophageal lesions and mechanisms of GERD development, occurring during the NSAIDs’ administration (including low doses of acetylsalicylic acid) and other drugs. The structure of drug-induced lesions of the upper gastrointestinal tract in patients taking NSAIDs has been analyzed. The investigation has been performed to study the frequency and characteristics of esophageal lesions in patients with osteoarthrosis of large joints, receiving NSAID treatment, as well as to determine factors that increase risk of developing this pathology. With account of the considered risk factors, the most rational approach to the diagnosis and primary prevention of NSAID-induced esophagitis has been chosen, which in most cases should reduce the incidence of side effects of NSAID-associated lesions of the esophagus. The main directions in the treatment of NSAID-associated injuries of the esophagus, namely, lifestyle change, balanced diet, changing the dose and regimen of NSAIDs or switching to selective NSAIDs, modern pharmacotherapy and surgical treatment have been elucidated. Clinical examples of patients with esophagus and stomach injuries associated with the long-term administration of NSAIDs and antiplatelet drugs were used to discuss the prevention and treatment of this category of patients, using proton pump inhibitors and bismuth-containing drugs.
Authors and Affiliations
O. O. Bondarenko, O. M. Agibalov
Keywords
Related Articles
- EP ID EP575132
- DOI 10.30978/MG-2019-2-55
- Views 93
- Downloads 0
Idiopathic non-cirrhotic portal hypertension and Budd — Chiari syndrome: focus on the problem
The idiopathic non-cytolytic portal hypertension and Budd — Chiari syndrome refer to orphan diseases, however last time the incidence of these liver diseases is being increased recently, especially among young people. Th...
The evaluation of specific changes and diagnostic informativeness of the cytokine profile in young patients with gastroesophageal reflux disease, occurring against the background of autoimmune inflammation
Objective — to determine the general trend of changes in the indicators of systemic inflammation — interleukin-1β and interleukin-18, in young patients with gastroesophageal reflux disease (GERD) and autoimmune thyroidit...
The visualized colon hyperpneumatosis, accompanied with the developed clinical symptoms, caused by Chilaiditi syndrome and dolichosigma. A clinical case
In the year 1910, Demetrius Chilaiditi described asymptomatic cases that looked like locations of intraabdominal free air at the routine abdominal or chest X-ray examination, which were caused by interposition of the col...
The peculiarities of some gastroenterological diseases in elderly patients
The data presented in the paper were based on the recent investigations and currentrecommendations. The pathological changes in the gastroenterological profile are proved to be most prevalent in subjects aged 65 years an...
New directions in the treatment of irritable bowel syndrome: focus on microbiosis
Fecal transplantation (FT) is the process of transplanting purified fecal material from a healthy donor to a recipient. The available evidence confirmed the positive role of FT in the treatment of a number of diseases, i...